SCHEMBL25846323

SCHEMBL25846323

NCCOCCC(=O)OC(c1ccccc1)(c1ccc(C2CCCCCCCCCC2)cc1)c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.40
FFAR4 Q5NUL3 2/20 0.34
FFAR2 O15552 1/20 0.34
P2RY14 Q15391 1/20 0.34
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
PTGDR2 Q9Y5Y4 3/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
OPRL1 P41146 1/20 0.32
HAO1 Q9UJM8 1/20 0.31
SLC6A1 P30531 1/20 0.31
CCR1 P32246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25846388 1.00 KIF11 (0.40) KIF11FFAR4FFAR2P2RY14CYP3A4
SCHEMBL26045321 1.00 KIF11 (0.40) KIF11FFAR4FFAR2P2RY14CYP3A4
SCHEMBL21562102 0.92 KIF11 (0.40) KIF11FFAR4FFAR2P2RY14CYP3A4
SCHEMBL21315939 0.92 KIF11 (0.40) KIF11FFAR4FFAR2P2RY14CYP3A4
SCHEMBL21118969 0.92 KIF11 (0.40) KIF11FFAR4FFAR2P2RY14CYP3A4
SCHEMBL21385478 0.87 KIF11 (0.45) KIF11FFAR4FFAR2CYP3A4CYP2C9
SCHEMBL18558846 0.87 KIF11 (0.45) KIF11FFAR4FFAR2CYP3A4CYP2C9
SCHEMBL18848228 0.87 KIF11 (0.45) KIF11FFAR4FFAR2CYP3A4CYP2C9
SCHEMBL22828015 0.87 KIF11 (0.45) KIF11FFAR4FFAR2CYP3A4CYP2C9
SCHEMBL20341164 0.87 KIF11 (0.45) KIF11FFAR4FFAR2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226193-A1 LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS Arrowhead Pharmaceuticals, Inc. 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230226193-A1 LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS CPT1B, MUSK, MYLK2 KIF11 367/4885FFAR4 1552/4885FFAR2 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.